Indietro

Selezionare la regione

Azienda

Europa:

Bandiera Albanien Albanien Bandiera Bosnia ed Erzegovina Bosnia ed Erzegovina Bandiera Bulgaria Bulgaria Bandiera Croazia Croazia Bandiera Cyprus Cyprus Bandiera Montenegro Montenegro Bandiera Repubblica Ceca Repubblica Ceca Bandiera Danimarca Danimarca Bandiera Estonia Estonia Bandiera Spagna Spagna Bandiera Kosovo Kosovo Bandiera Lituania Lituania Bandiera Lettonia Lettonia Bandiera Lussemburgo Lussemburgo Bandiera Macedonia Macedonia Bandiera Germania Germania Bandiera Polonia Polonia Bandiera Portogallo Portogallo Bandiera Romania Romania Bandiera Serbia Serbia Bandiera Slovacchia Slovacchia Bandiera Slovenia Slovenia Bandiera Svizzera Svizzera Bandiera Svezia Svezia Bandiera Turchia Turchia Bandiera Ucraina Ucraina Bandiera Ungheria Ungheria Bandiera Regno Unito Regno Unito Bandiera Italia Italia

Asia:

Bandiera Emirati Arabi Uniti Emirati Arabi Uniti Bandiera Hong Kong Hong Kong Bandiera Kuwait Kuwait Bandiera Libano Libano

Africa:

Bandiera Sudafrica Sudafrica

Richiedi un consulto sulle cellule staminali

Per saperne di più

Mettetevi in contatto con noi oggi stesso!

Volete saperne di più sui nostri servizi? Compilate il modulo sottostante e vi contatteremo al più presto per fornirvi tutte le informazioni necessarie e rispondere alle vostre domande.

    +41
    • United Kingdom+44
    • Albania (Shqipëri)+355
    • Andorra+376
    • Armenia (Հայաստան)+374
    • Austria (Österreich)+43
    • Azerbaijan (Azərbaycan)+994
    • Belarus (Беларусь)+375
    • Belgium (België)+32
    • Bosnia and Herzegovina (Босна и Херцеговина)+387
    • Bulgaria (България)+359
    • Croatia (Hrvatska)+385
    • Cyprus (Κύπρος)+357
    • Czech Republic (Česká republika)+420
    • Denmark (Danmark)+45
    • Estonia (Eesti)+372
    • Finland (Suomi)+358
    • France+33
    • Georgia (საქართველო)+995
    • Germany (Deutschland)+49
    • Greece (Ελλάδα)+30
    • Hungary (Magyarország)+36
    • Iceland (Ísland)+354
    • Ireland+353
    • Italy (Italia)+39
    • Kazakhstan (Казахстан)+7
    • Latvia (Latvija)+371
    • Liechtenstein+423
    • Lithuania (Lietuva)+370
    • Luxembourg+352
    • Macedonia (FYROM) (Македонија)+389
    • Malta+356
    • Moldova (Republica Moldova)+373
    • Monaco+377
    • Montenegro (Crna Gora)+382
    • Netherlands (Nederland)+31
    • Norway (Norge)+47
    • Poland (Polska)+48
    • Portugal+351
    • Romania (România)+40
    • Russia (Россия)+7
    • San Marino+378
    • Serbia (Србија)+381
    • Slovakia (Slovensko)+421
    • Slovenia (Slovenija)+386
    • Spain (España)+34
    • Sweden (Sverige)+46
    • Switzerland (Schweiz)+41
    • Turkey (Türkiye)+90
    • Ukraine (Україна)+380
    • United Kingdom+44
    • Vatican City (Città del Vaticano)+39

    Si precisa che i dati personali forniti nel modulo saranno trattati da FamiCord Suisse, con sede in Svizzera (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), allo scopo di contattarvi telefonicamente per la fornitura di informazioni sui servizi.

    Immagine

    Elenco dei
    trapianti

    Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo Famicord.

    Immagine
    Lp.
    Fonte
    Tipo di fonte
    Diagnosi
    Settore medico
    Anno di applicazione
    Terapia
    Paese
    Età del destinatario
    Tutti
    Tutti
    Tutti
    Tutti
    Tutti
    Tutti
    Tutti
    Tutti
    1
    Cord Tissue
    Allogeneic - Related
    Chronic renal disease
    Endocrinology
    2025
    Experimental Therapy
    Romania
    50
    2
    Cord Tissue
    Allogeneic - Related
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    3
    Cord Tissue
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    4
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedy
    2025
    Experimental Therapy
    Poland
    57
    5
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    6
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    7
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    2
    8
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    5
    9
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    11
    10
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    54
    11
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    78
    12
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    6
    13
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    58
    14
    Cord Tissue
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    15
    Cord Tissue
    Allogeneic - Related
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    16
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    4
    17
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    18
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    19
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    5
    20
    Cord Blood
    Autologous
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    2
    21
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    22
    Cord Blood
    Allogeneic - Related
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Portugal
    1
    23
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    24
    Cord Blood
    Allogeneic
    Acute lymphoblastic leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    13
    25
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    5
    26
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    27
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    Poland
    71
    28
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    United Kingdom
    72
    29
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    47
    30
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Ukraine
    43
    31
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    49
    32
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    51
    33
    Bone Marrow Family
    Allogeneic
    Philadelphia - positive Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    61
    34
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    58
    35
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    63
    36
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    65
    37
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    France
    63
    38
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    68
    39
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    France
    71
    40
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Russia
    51
    41
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    62
    42
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Czechia
    54
    43
    Bone Marrow
    Allogeneic
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Spain
    15
    44
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Norway
    55
    45
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    3
    46
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    7
    47
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    36
    48
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    10
    49
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    USA
    76
    50
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    51
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    South Africa
    6
    52
    Bone Marrow
    Allogeneic
    Wiskott-Aldrich syndrome
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    53
    Bone Marrow
    Allogeneic
    Combined immnunodeficiency
    Hematology
    2025
    Standard Therapy
    Ukraine
    3
    54
    Bone Marrow
    Allogeneic
    Chronic Granulomatous Disease
    Hematology
    2025
    Standard Therapy
    Poland
    3
    55
    Bone Marrow
    Allogeneic
    Mixed Phenotype Acute Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    13
    56
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    7
    57
    Bone Marrow
    Allogeneic
    B-cell precursor Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    56
    58
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    43
    59
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    19
    60
    Bone Marrow
    Allogeneic
    Very Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    12
    61
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    5
    62
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    10
    63
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    6
    64
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    44
    65
    Bone Marrow
    Allogeneic
    Paroxysmal Nocturnal Hemoglobinuria
    Hematology
    2025
    Standard Therapy
    Poland
    25
    66
    Bone Marrow
    Allogeneic
    Juvenile Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    67
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    USA
    21
    68
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    12
    69
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Hungary
    10
    70
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Czechia
    68
    71
    Bone Marrow
    Allogeneic
    Adrenoleukodystrophy
    Hematology
    2025
    Standard Therapy
    Poland
    53
    72
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    4
    73
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    France
    4
    74
    Bone Marrow
    Allogeneic
    Paroxysmal Nocturnal Hemoglobinuria
    Hematology
    2025
    Standard Therapy
    Norway
    18
    75
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    76
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    34
    77
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    61
    78
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome/Myeloproliferative neoplasm
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    62
    79
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    68
    80
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    70
    81
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    66
    82
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    77
    83
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    12
    84
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    85
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    67
    86
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    87
    Apheresis
    Allogeneic
    Myelofibrosis Myeloid Metaplasia
    Hematology
    2025
    Standard Therapy
    USA
    73
    88
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    56
    89
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    50
    90
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    91
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Lithuania
    43
    92
    Apheresis
    Allogeneic
    Chronic Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    66
    93
    Apheresis
    Allogeneic
    Multiple Myeloma
    Hematology
    2025
    Standard Therapy
    USA
    61
    94
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    55
    95
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    69
    96
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Denmark
    67
    97
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    United Kingdom
    75
    98
    Apheresis
    Allogeneic
    T - cell Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    24
    99
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Belgium
    68
    100
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    42
    Pagina
    von77
    100 Righe
    Caricamento